Chemoinformaics analysis of 2-(2,4-Hexadiynylidene)-1,6-dioxaspiro[4,4]non-3-ene
Molecular Weight | 204.269 | nRot | 2 |
Heavy Atom Molecular Weight | 188.141 | nRig | 13 |
Exact Molecular Weight | 204.115 | nRing | 2 |
Solubility: LogS | -2.075 | nHRing | 2 |
Solubility: LogP | 1.246 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 33.9827 |
nHD | 0 | BPOL | 19.5233 |
QED | 0.643 |
Synth | 4.713 |
Natural Product Likeliness | 2.406 |
NR-PPAR-gamma | 0.009 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.008 |
Pgp-sub | 0.012 |
HIA | 0.005 |
CACO-2 | -4.512 |
MDCK | 0.0000193 |
BBB | 0.888 |
PPB | 0.831609 |
VDSS | 0.694 |
FU | 0.110437 |
CYP1A2-inh | 0.471 |
CYP1A2-sub | 0.746 |
CYP2c19-inh | 0.78 |
CYP2c19-sub | 0.846 |
CYP2c9-inh | 0.191 |
CYP2c9-sub | 0.937 |
CYP2d6-inh | 0.918 |
CYP2d6-sub | 0.913 |
CYP3a4-inh | 0.798 |
CYP3a4-sub | 0.326 |
CL | 9.172 |
T12 | 0.372 |
hERG | 0.054 |
Ames | 0.071 |
ROA | 0.112 |
SkinSen | 0.957 |
Carcinogencity | 0.714 |
EI | 0.611 |
Respiratory | 0.764 |
NR-Aromatase | 0.041 |
Antiviral | Yes |
Prediction | 0.603212 |